Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin

      Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin

      Medical Dialogues Bureau24 Dec 2019 12:05 PM IST
      Under the sub-licensing agreement, Mankind will market diabetes drug Remogliflozin Etabonate under its own trademark while Glenmark will manufacture...
      FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

      FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

      Medical Dialogues Bureau24 Dec 2019 9:45 AM IST
      Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
      Trivitron Healthcare gets Ravish Mittal as new Group CFO

      Trivitron Healthcare gets Ravish Mittal as new Group CFO

      Medical Dialogues Bureau24 Dec 2019 9:32 AM IST
      'In his new role, Ravish Mittal will be at the helm of the company's finances, organisational growth and expansion plans,' Trivitron Healthcare...
      Allergan acute migraine drug Ubrelvy wins USFDA approval

      Allergan acute migraine drug Ubrelvy wins USFDA approval

      Medical Dialogues Bureau24 Dec 2019 9:30 AM IST
      Allergan Plc's drug, Ubrelvy, is the first oral version of a new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors to win the...
      Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations

      Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations

      Medical Dialogues Bureau24 Dec 2019 9:00 AM IST
      The vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
      Johnson and Johnson wins baby powder-cancer litigation case in US

      Johnson and Johnson wins baby powder-cancer litigation case in US

      Medical Dialogues Bureau23 Dec 2019 12:43 PM IST
      The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson (JnJ), finding Johnson's baby powder...
      Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA

      Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA

      Medical Dialogues Bureau23 Dec 2019 10:00 AM IST
      "Glenmark will continue to fully cooperate with the FDA as the agency evaluates ranitidine products for the presence of NDMA (a substance that could...
      Lupin to provide access to latest developments in field of gastroenterology in India

      Lupin to provide access to latest developments in field of gastroenterology in India

      Medical Dialogues Bureau23 Dec 2019 9:45 AM IST
      Through this initiative, Lupin aims to bring in global educational material and provide access to the latest developments in the field of...
      GSK fails to secure USFDA nod for HIV injection Cabenuva

      GSK fails to secure USFDA nod for HIV injection Cabenuva

      Medical Dialogues Bureau23 Dec 2019 9:40 AM IST
      The unit of GSK, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new...
      IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney

      IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney

      Medical Dialogues Bureau23 Dec 2019 9:00 AM IST
      It has focused on breast tumours, but now the U.S. Food and Drug Administration (USFDA) approved new uses, such as against tumours in the kidney,...
      NPPA fixes price of Cipla Synchrobreathe inhaler device; Details

      NPPA fixes price of Cipla Synchrobreathe inhaler device; Details

      Medical Dialogues Bureau22 Dec 2019 2:26 PM IST
      New Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
      Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil

      Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil

      Medical Dialogues Bureau22 Dec 2019 10:01 AM IST
      "Today, the manufacturing cost of atovaquone is believed to pose a barrier to the widespread use of atovaquone-proguanil based products in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok